JP2019513775A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019513775A5 JP2019513775A5 JP2018553445A JP2018553445A JP2019513775A5 JP 2019513775 A5 JP2019513775 A5 JP 2019513775A5 JP 2018553445 A JP2018553445 A JP 2018553445A JP 2018553445 A JP2018553445 A JP 2018553445A JP 2019513775 A5 JP2019513775 A5 JP 2019513775A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- selenium
- amino acid
- containing amino
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 34
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims 9
- 235000001014 amino acid Nutrition 0.000 claims 9
- 150000001413 amino acids Chemical class 0.000 claims 9
- 229910052711 selenium Inorganic materials 0.000 claims 9
- 239000011669 selenium Substances 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 8
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims 5
- FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 claims 4
- RJFAYQIBOAGBLC-UHFFFAOYSA-N 2-amino-4-methylselanyl-butanoic acid Chemical compound C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 claims 4
- 238000011200 topical administration Methods 0.000 claims 4
- 206010020649 Hyperkeratosis Diseases 0.000 claims 3
- 208000001126 Keratosis Diseases 0.000 claims 3
- 210000000744 eyelid Anatomy 0.000 claims 3
- 230000000699 topical effect Effects 0.000 claims 3
- 206010065062 Meibomian gland dysfunction Diseases 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
- 239000004342 Benzoyl peroxide Substances 0.000 claims 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 1
- 206010013774 Dry eye Diseases 0.000 claims 1
- 229940124091 Keratolytic Drugs 0.000 claims 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 1
- 239000000853 adhesive Substances 0.000 claims 1
- 230000001070 adhesive effect Effects 0.000 claims 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims 1
- 229940061720 alpha hydroxy acid Drugs 0.000 claims 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims 1
- 235000019400 benzoyl peroxide Nutrition 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000011280 coal tar Substances 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- -1 ditranol Chemical compound 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000001530 keratinolytic effect Effects 0.000 claims 1
- 239000003410 keratolytic agent Substances 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 229960000448 lactic acid Drugs 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 229930002330 retinoic acid Natural products 0.000 claims 1
- 229960004889 salicylic acid Drugs 0.000 claims 1
- 229910000338 selenium disulfide Inorganic materials 0.000 claims 1
- JNMWHTHYDQTDQZ-UHFFFAOYSA-N selenium sulfide Chemical compound S=[Se]=S JNMWHTHYDQTDQZ-UHFFFAOYSA-N 0.000 claims 1
- 229960005265 selenium sulfide Drugs 0.000 claims 1
- 229960001727 tretinoin Drugs 0.000 claims 1
- 229940045136 urea Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662324795P | 2016-04-19 | 2016-04-19 | |
| US62/324,795 | 2016-04-19 | ||
| PCT/IB2017/000638 WO2017182885A2 (en) | 2016-04-19 | 2017-04-18 | Compositions for the treatment of hyperkeratosis disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019513775A JP2019513775A (ja) | 2019-05-30 |
| JP2019513775A5 true JP2019513775A5 (https=) | 2020-06-18 |
Family
ID=60115757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018553445A Pending JP2019513775A (ja) | 2016-04-19 | 2017-04-18 | 角化症の処置のための組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20200179305A1 (https=) |
| EP (1) | EP3445352A4 (https=) |
| JP (1) | JP2019513775A (https=) |
| KR (1) | KR20180133913A (https=) |
| CN (1) | CN109328061A (https=) |
| AU (1) | AU2017252026A1 (https=) |
| CA (1) | CA3020713A1 (https=) |
| IL (1) | IL262348A (https=) |
| MA (1) | MA44737A (https=) |
| WO (1) | WO2017182885A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9463201B2 (en) | 2014-10-19 | 2016-10-11 | M.G. Therapeutics Ltd | Compositions and methods for the treatment of meibomian gland dysfunction |
| US10688122B2 (en) * | 2015-09-28 | 2020-06-23 | Azura Ophthalmics Ltd. | Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion |
| US11040062B2 (en) | 2016-04-14 | 2021-06-22 | Azura Ophthalmics Ltd. | Selenium disulfide compositions for use in treating meibomian gland dysfunction |
| EP3525770A4 (en) | 2016-10-12 | 2020-08-26 | JDS Therapeutics, LLC | MAGNESIUM PICOLINATE COMPOSITIONS AND METHODS OF USE |
| CN108840904B (zh) * | 2018-07-12 | 2022-03-04 | 江西中科硒谷功能农业发展有限公司 | 一种从烟叶中提取硒蛋白质的方法 |
| JP7142286B2 (ja) * | 2018-07-13 | 2022-09-27 | 慶應義塾 | セレン含有アミノ酸を含む糖鎖－ポリペプチド複合体、および、その医薬用途 |
| WO2020212755A1 (en) * | 2019-04-18 | 2020-10-22 | Azura Ophthalmics Ltd. | Compounds and methods for the treatment of ocular disorders |
| EP3955937A4 (en) | 2019-04-18 | 2023-01-18 | Azura Ophthalmics Ltd. | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES |
| JP7700045B2 (ja) | 2019-04-18 | 2025-06-30 | アズーラ オフサルミックス エルティーディー． | 眼障害を処置するための化合物および方法 |
| US20200345768A1 (en) * | 2019-05-01 | 2020-11-05 | Nutrition 21, Llc | Zinc picolinate, magnesium picolinate and selenium methionine compositions and methods of use |
| EP4087655A4 (en) | 2020-01-10 | 2024-02-21 | Azura Ophthalmics Ltd | INSTRUCTIONS FOR COMPOSITION AND SENSITIVITY |
| EP4232034A4 (en) * | 2020-10-21 | 2024-12-04 | Azura Ophthalmics Ltd | COMPOUNDS AND METHODS FOR TREATING EYE DISORDERS |
| US11459351B1 (en) | 2021-04-05 | 2022-10-04 | Azura Ophthalmics Ltd. | Compounds and methods for the treatment of ocular disorders |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6011067A (en) * | 1999-06-11 | 2000-01-04 | Thione International, Inc. | Antioxidant composition for the treatment of psoriasis and related diseases |
| US6495158B1 (en) * | 2001-01-19 | 2002-12-17 | Lec Tec Corporation | Acne patch |
| US20020127256A1 (en) * | 2001-03-01 | 2002-09-12 | Howard Murad | Compositions and methods for treating dermatological disorders |
| US20030224028A1 (en) * | 2002-05-13 | 2003-12-04 | Societe L'oreal S.A. | Metal complexes for promoting skin desquamation and/or stimulating epidermal renewal |
| US20050065091A1 (en) * | 2003-09-18 | 2005-03-24 | Gholam Peyman | Stabilized ocular solutions |
| US20080025929A1 (en) * | 2004-02-19 | 2008-01-31 | Chemaphor, Inc. | Topical Formulations for the Treatment of Skin Conditions |
| PT1791423E (pt) * | 2004-08-02 | 2013-08-02 | Sami Labs Ltd | Composições e métodos para o tratamento de condições dermatológicas hiperproliferativas |
| US7776915B2 (en) * | 2005-03-24 | 2010-08-17 | Tracie Martyn International, Llc | Topical formulations and methods of use |
| CN101203236A (zh) * | 2005-06-22 | 2008-06-18 | 坪田一男 | 角结膜疾病的预防或治疗剂 |
| US20130064788A1 (en) * | 2009-10-10 | 2013-03-14 | Eleven Biotherapeutics, Inc. | Il-17 family cytokine compositions and uses |
| US8765725B2 (en) * | 2012-05-08 | 2014-07-01 | Aciex Therapeutics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
| US10500255B2 (en) * | 2012-12-21 | 2019-12-10 | Aqua Bio Technology Asa | Cosmetic compositions from fish hatching fluid |
| US9463201B2 (en) * | 2014-10-19 | 2016-10-11 | M.G. Therapeutics Ltd | Compositions and methods for the treatment of meibomian gland dysfunction |
-
2017
- 2017-04-18 JP JP2018553445A patent/JP2019513775A/ja active Pending
- 2017-04-18 CA CA3020713A patent/CA3020713A1/en not_active Abandoned
- 2017-04-18 EP EP17785520.2A patent/EP3445352A4/en not_active Withdrawn
- 2017-04-18 KR KR1020187033299A patent/KR20180133913A/ko not_active Ceased
- 2017-04-18 AU AU2017252026A patent/AU2017252026A1/en not_active Abandoned
- 2017-04-18 US US16/093,616 patent/US20200179305A1/en not_active Abandoned
- 2017-04-18 CN CN201780038116.6A patent/CN109328061A/zh active Pending
- 2017-04-18 MA MA044737A patent/MA44737A/fr unknown
- 2017-04-18 WO PCT/IB2017/000638 patent/WO2017182885A2/en not_active Ceased
-
2018
- 2018-10-14 IL IL262348A patent/IL262348A/en unknown
-
2022
- 2022-04-20 US US17/725,320 patent/US20230013824A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019513775A5 (https=) | ||
| WO2017182885A3 (en) | Compositions for the treatment of hyperkeratosis disorders | |
| ES2958621T3 (es) | Composiciones para el tratamiento tópico de infecciones microbianas | |
| JP2011116787A5 (https=) | ||
| RU2016135952A (ru) | Композиции ингибитора дофа-декарбоксилазы | |
| MX2017014804A (es) | Composiciones farmaceuticas topicas. | |
| JP2016540785A5 (https=) | ||
| RU2015122627A (ru) | Кожные композиции, содержащие неприродные гигроскопические аминокислоты | |
| JP2017507973A5 (https=) | ||
| JP2018528259A5 (https=) | ||
| ES2289527T3 (es) | Uso de una composicion reestructurante de uñas para aplicacion topica en onicosquisis. | |
| MX2022014577A (es) | Gel intestinal de levodopa y carbidopa y metodos de uso. | |
| BR112015027992A2 (pt) | uso de ácido petroselínico para combater desordens estéticas da figura do corpo | |
| JPWO2022138842A5 (https=) | ||
| CN102105142A (zh) | 用于治疗红斑狼疮的包括壳聚糖和二羧酸的组合物 | |
| RU2015145451A (ru) | Препараты для местного применения, содержащие гиалуроновую кислоту, вербаскозид и глицерофосфоинозитол | |
| RU2012130852A (ru) | Фармацевтическая композиция для местного применения при лечении воспалительных заболеваний глаз и способ ее использования | |
| CO2023011644A2 (es) | Composición antitranspirante | |
| JP2004107242A (ja) | 乾燥肌改善用キット | |
| ES2641561T3 (es) | Sistema a base de magnesio y su uso en cosmética | |
| JPWO2022138826A5 (https=) | ||
| JP2012206961A (ja) | 抗菌剤及び皮膚外用剤 | |
| US11672769B2 (en) | Paraffin wax with CBD isolate | |
| JP6558117B2 (ja) | 皮膚用剤 | |
| RU2013148949A (ru) | Местный состав, содержащий кортикостероид в качестве активного ингредиента |